Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

Clinical trial NCT05407441 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05407441
Sponsor: Susan Chi, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atypical Teratoid Rhabdoid Tumor INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors SMARCA4-deficient Primary CNS Malignant Tumors Malignant Rhabdoid Tumor (MRT)Rhabdoid Tumor of the Kidney (RTK)Epithelioid Sarcoma Chordoma

Start date: 2023-08-10
Primary completion: 2027-02-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.